Wasatch Advisors Inc decreased its stake in Chemocentryx Inc (CCXI) by 2.76% based on its latest 2018Q4 regulatory filing with the SEC. Wasatch Advisors Inc sold 65,931 shares as the company’s stock rose 6.99% with the market. The institutional investor held 2.32M shares of the health care company at the end of 2018Q4, valued at $25.35 million, down from 2.39 million at the end of the previous reported quarter. Wasatch Advisors Inc who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $748.13 million market cap company. The stock decreased 4.78% or $0.65 during the last trading session, reaching $12.96. About 319,089 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since April 30, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M
Tci Wealth Advisors Inc decreased its stake in Wells Fargo Co New (WFC) by 66.67% based on its latest 2018Q4 regulatory filing with the SEC. Tci Wealth Advisors Inc sold 9,388 shares as the company’s stock declined 7.80% while stock markets rallied. The institutional investor held 4,693 shares of the major banks company at the end of 2018Q4, valued at $216,000, down from 14,081 at the end of the previous reported quarter. Tci Wealth Advisors Inc who had been investing in Wells Fargo Co New for a number of months, seems to be less bullish one the $218.33 billion market cap company. The stock increased 0.25% or $0.12 during the last trading session, reaching $48.39. About 8.84M shares traded. Wells Fargo & Company (NYSE:WFC) has declined 12.56% since April 30, 2018 and is downtrending. It has underperformed by 16.93% the S&P500. Some Historical WFC News: 04/05/2018 – Union Investment Achieves $480 Million Recovery for Shareholders in Wells Fargo Securities Class Action; 13/04/2018 – WELLS FARGO & CO QTRLY PRELIMINARY AVERAGE LOANS OF $951.0 BLN, DOWN $12.6 BLN, OR 1 PERCENT; 19/04/2018 – US regulators to hit Wells Fargo with $1bn fine; 08/05/2018 – Conversations About Elder Needs Aren’t Happening, According to Wells Fargo Survey; 27/04/2018 – Allegion to Attend 2018 Wells Fargo Industrials Conference; 23/03/2018 – Wells Fargo’s four top risk management executives to retire: DJ; 08/05/2018 – Brady Presenting at Wells Fargo Industrials Conference Tomorrow; 12/04/2018 – Teacher’s Union Gives Wells Fargo An Ultimatum On Guns — MarketWatch; 05/04/2018 – WELLS FARGO SALES PUSH EXTENDED TO WEALTH UNIT, EX-WORKERS SAY; 12/04/2018 – TriMas Presenting at Wells Fargo Industrials Conference May 8
Investors sentiment decreased to 0.93 in 2018 Q4. Its down 0.05, from 0.98 in 2018Q3. It fall, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. Baker Bros Advsrs Limited Partnership invested in 0.02% or 207,029 shares. National Bank Of Ny Mellon Corporation holds 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 139,805 shares. Credit Suisse Ag has 10,418 shares. Tower Cap Limited Liability Company (Trc) holds 257 shares or 0% of its portfolio. Financial Bank Of America Corp De has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 93,623 shares. Ameriprise Fin invested in 264,496 shares or 0% of the stock. Voya Inv Management Ltd reported 10,588 shares or 0% of all its holdings. 19,773 were reported by Citadel Advsrs Ltd Liability. Bvf Incorporated Il invested in 9.54% or 6.69 million shares. 45,500 were accumulated by J Goldman & Commerce Limited Partnership. Cadence Capital Management Ltd Liability Co holds 0.11% or 103,341 shares. Bb&T Secs Ltd Liability Corp holds 0.01% or 114,827 shares. Alliancebernstein Lp reported 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). California State Teachers Retirement System invested in 35,245 shares or 0% of the stock. 3,615 were reported by Legal General Public Limited Company.
Since November 7, 2018, it had 0 insider purchases, and 6 selling transactions for $1.47 million activity. The insider Cappel Markus J. sold 13,203 shares worth $158,790. 37,893 shares were sold by KANAYA SUSAN M, worth $457,747.
Wasatch Advisors Inc, which manages about $19.28 billion and $7.50 billion US Long portfolio, upped its stake in Healthequity Inc (NASDAQ:HQY) by 83,388 shares to 1.66 million shares, valued at $99.17 million in 2018Q4, according to the filing. It also increased its holding in Five9 Inc (NASDAQ:FIVN) by 881,751 shares in the quarter, for a total of 1.77 million shares, and has risen its stake in Neogen Corp (NASDAQ:NEOG).
More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Seekingalpha.com which released: “ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” on March 12, 2019, also Globenewswire.com with their article: “ChemoCentryx Appoints Rita Jain, M.D. to Board of Directors – GlobeNewswire” published on March 28, 2019, Globenewswire.com published: “Presentations at ASN Kidney Week 2018 Highlight ChemoCentryx Platform in Treatment of ANCA-Associated Vasculitis and Focal Segmental Glomerulosclerosis (FSGS) – GlobeNewswire” on October 25, 2018. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Globenewswire.com and their article: “ChemoCentryx’s Novel Small Molecule Antagonists of Checkpoint Inhibitors and Chemokine Receptors to be Presented at the American Association for Cancer Research (AACR) Tumor Immunology and Immunotherapy Conference – GlobeNewswire” published on November 29, 2018 as well as Seekingalpha.com‘s news article titled: “Premarket analyst action – healthcare – Seeking Alpha” with publication date: September 07, 2018.
Tci Wealth Advisors Inc, which manages about $1.53B and $206.43M US Long portfolio, upped its stake in Western Alliance Bancorp (NYSE:WAL) by 20,737 shares to 24,712 shares, valued at $976,000 in 2018Q4, according to the filing. It also increased its holding in Apple Inc (Call) (NASDAQ:AAPL) by 7,300 shares in the quarter, for a total of 8,800 shares, and has risen its stake in Visa Inc (NYSE:V).
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.